• No results found

[PDF] Top 20 The Structural Characterization of Recombinant Human Granulocyte Colony Stimulating Factor

Has 10000 "The Structural Characterization of Recombinant Human Granulocyte Colony Stimulating Factor" found on our website. Below are the top 20 most common "The Structural Characterization of Recombinant Human Granulocyte Colony Stimulating Factor".

The Structural Characterization of Recombinant Human Granulocyte Colony Stimulating Factor

The Structural Characterization of Recombinant Human Granulocyte Colony Stimulating Factor

... For confirmation of rh-GCSF band in gel, western blotting with polyclonal human GCSF antibody was performed. Separated proteins on the SDS-PAGE gels were transferred into a poly-vinylidene fluoride (PVDF) membrane ... See full document

5

Cloning and expression of recombinant human granulocyte-macrophage colony stimulating factor (rhGMCSF) in Escherichia coli

Cloning and expression of recombinant human granulocyte-macrophage colony stimulating factor (rhGMCSF) in Escherichia coli

... The product obtained in this study was inclusion body that needed the stages of rinsing and solution. Inclusion body formation has some advantages like formation of more products because of low toxicity of inclusion body ... See full document

5

Recombinant Human Granulocyte Colony Stimulating
Factor (Rh G-CSF) Administered Before, During and
After High Dose Chemotherapy to Patients with Acute
Myeloid Leukemia: Effect on Hematopoiesis and Bone
Marrow Microenvironment

Recombinant Human Granulocyte Colony Stimulating Factor (Rh G-CSF) Administered Before, During and After High Dose Chemotherapy to Patients with Acute Myeloid Leukemia: Effect on Hematopoiesis and Bone Marrow Microenvironment

... In all patients Rh G-CSF appeared very effective in inducing granulocytic proliferation during the early (2-4 weeks) and late (5-8 weeks) phases of hematopoietic regeneration. In all cases a proliferation of eosinophilic ... See full document

9

Granulocyte Colony-Stimulating Factor Serum and Urine Concentrations in Neutropenic Neonates Before and After Intravenous Administration of Recombinant Granulocyte Colony-Stimulating Factor

Granulocyte Colony-Stimulating Factor Serum and Urine Concentrations in Neutropenic Neonates Before and After Intravenous Administration of Recombinant Granulocyte Colony-Stimulating Factor

... G-CSF Enzyme-Linked Immunosorbent Assay (ELISA) Serum and urine samples were aliquoted and stored at ⫺ 80°C until analysis. G-CSF was quantified by ELISA (lower limit of sensitivity: 7 pg/mL; Quantikine Human ... See full document

8

Recombinant Granulocyte Colony-Stimulating Factor Administered Enterally to Neonates Is Not Absorbed

Recombinant Granulocyte Colony-Stimulating Factor Administered Enterally to Neonates Is Not Absorbed

... Neonates admitted to the neonatal intensive care unit of Shands Children’s Hospital at the University of Florida were considered eligible for study if they were ⬍ 1 month old at time of study entry, if they were deemed ... See full document

5

In vivo Characterization of Fusion Protein Comprising of A1 Subunit of Shiga Toxin and Human GM-CSF: Assessment of Its Immunogenicity and Toxicity

In vivo Characterization of Fusion Protein Comprising of A1 Subunit of Shiga Toxin and Human GM-CSF: Assessment of Its Immunogenicity and Toxicity

... of human cancer has been developed using immunotoxins which comprise both the cell targeting and the cell killing ...the recombinant Shiga toxin A1 subunit fused to human ... See full document

6

Preliminary Report: rhG-CSF May Reduce the Incidence of Neonatal Sepsis in Prolonged Preeclampsia-associated Neutropenia

Preliminary Report: rhG-CSF May Reduce the Incidence of Neonatal Sepsis in Prolonged Preeclampsia-associated Neutropenia

... To determine whether ad- junctive therapy with recombinant human granulocyte colony-stimulating factor (rhG-CSF) could reverse the neutropenia and reduce the incidence of sepsis ( < 2[r] ... See full document

7

Human granulocyte colony stimulating factor (hG-CSF): cloning, overexpression, purification and characterization

Human granulocyte colony stimulating factor (hG-CSF): cloning, overexpression, purification and characterization

... The appropriate genetics for soluble protein production has not yet been established and thus prevention of inclu- sion body formation is essentially a trial-and-error proc- ess. Aggregation may be minimized by ... See full document

12

Biology and Clinical Applications of Hemopoietins in Pediatric Practice

Biology and Clinical Applications of Hemopoietins in Pediatric Practice

... Phase I/Il study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Gabrilove JL, Jakubowski A, Fain K, e[r] ... See full document

15

Human recombinant granulocyte macrophage colony stimulating factor and interleukin 3 cause basophil histamine release

Human recombinant granulocyte macrophage colony stimulating factor and interleukin 3 cause basophil histamine release

... of human cells, including T lymphocytes and alveolar ...on human basophils and/or mast cells and therefore tested preparations of human recombinant IL 3, IL 4, IL 5, granulocyte ... See full document

5

Human granulocyte macrophage colony stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes

Human granulocyte macrophage colony stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes

... by recombinant GM-CSF(rGM-CSF)-treated U937 cells was found to exert an inhibitory effect on subsequent U937 colony growth that was partially due to the presence of tumor necrosis factor ... See full document

10

Recombinant Human Granulocyte Colony-stimulating Factor Therapy for Sepsis in Infants With Neutropenia

Recombinant Human Granulocyte Colony-stimulating Factor Therapy for Sepsis in Infants With Neutropenia

... A randomized, placebo- controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis.. Lieschke GJ[r] ... See full document

8

Human recombinant granulocyte macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities

Human recombinant granulocyte macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities

... of human recombinant IL-3 and granulocyte- macrophage colony stimulating factor (GM-CSF) were directly compared using highly enriched human bone marrow progenitor target ... See full document

7

A Randomized, Controlled Trial of Prophylactic Granulocyte-Macrophage Colony-Stimulating Factor in Human Newborns Less Than 32 Weeks Gestation

A Randomized, Controlled Trial of Prophylactic Granulocyte-Macrophage Colony-Stimulating Factor in Human Newborns Less Than 32 Weeks Gestation

... Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats.. Gillan ER, Chri[r] ... See full document

9

Human Granulocyte Colony-stimulating Factor May Improve Outcome Attributable to Neonatal Sepsis Complicated by Neutropenia

Human Granulocyte Colony-stimulating Factor May Improve Outcome Attributable to Neonatal Sepsis Complicated by Neutropenia

... Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats. Smith WS, Sumnic[r] ... See full document

8

Increased granulocyte colony stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony stimulating factor receptor mutation derived from a patient with severe congenital neutropenia

Increased granulocyte colony stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony stimulating factor receptor mutation derived from a patient with severe congenital neutropenia

... G-CSF administration to mice. Recombinant human G-CSF (Am- gen) was administered by daily subcutaneous injection at a dose of 10 m g/kg per day for 7 d. Peripheral blood was obtained before the first G-CSF ... See full document

11

Cleaning validation of recombinant human granulocyte colony stimulating factor (rhu gcsf) in multi product manufacturing facility: a case study

Cleaning validation of recombinant human granulocyte colony stimulating factor (rhu gcsf) in multi product manufacturing facility: a case study

... The equipments were rinsed with 150 ml of cooled WFI by covering the total surface of the equipment after completion of swab sampling. The rinsate were collected in depyrogenated glass bottles. The theoretical acceptance ... See full document

5

Original Article Modulation of the function of dendritic cells in adolescents with chronic HBV infection by IFN-λ1

Original Article Modulation of the function of dendritic cells in adolescents with chronic HBV infection by IFN-λ1

... with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) and recombinant human interleukin-4 (rhIL-4) can induce the DCs maturation and ... See full document

9

The effect of myeloid growth factors on phagocyte-endothelium interactions.

The effect of myeloid growth factors on phagocyte-endothelium interactions.

... Phase 1 clinical studies with rhGM-CSF demonstrated a dose dependent increase in circulating neutrophils, monocytes, eosinophils, and occasionally, lymphocytes (Lieschke et al, 1989b, Phillips et al, 1989). This was ... See full document

226

A screen for peptide agonists of the G CSF receptor

A screen for peptide agonists of the G CSF receptor

... We designed a 20-mer peptide library derived from the human G-CSF sequence with a sliding overlap of 2 amino acids. We first conducted a screen at a concentration of 1 μ M per peptide, a 10 4 -fold higher molarity ... See full document

6

Show all 10000 documents...

Related subjects